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ABSTRACT
The aim of this observational study was to describe the profile of subjects with type 2 diabetes mellitus from 
Gujarat, India. The study was performed with newly-diagnosed 622 type 2 diabetic subjects who attended 
the Department of Diabetology, All India Institute of Diabetes and Research and Yash Diabetes Specialties 
Centre (Swasthya), Ahmedabad, during August 2006–January 2009. The subjects completed an inter-
viewer-administered questionnaire. The questionnaire included variables, such as sociodemographic fac-
tors, presenting symptoms, risk profile (hypertension, obesity, dyslipidaemia, and glycaemic status), family 
history of diabetes, physical activity, and behavioural profile. Blood pressure, body mass index (BMI), glyco-
sylated haemoglobin levels, and fasting lipid profile were measured. Descriptive and bivariate analyses were 
carried out using the SPSS software (version 11.5). In total, 622 type 2 diabetes mellitus (T2DM) cases with 
mean age of 47.7±10.9 years were studied. Of the 622 subjects, 384 (62%) were male. The majority (68%) of 
the T2DM subjects were obese, and 67% had a positive family history of diabetes. Renal dysfunctions and 
vision impairment were, respectively, found in 10% (n=62) and 9% (n=57) of the 622 T2DM subjects. The 
mean HbA1c level was 9.02±1.67%, and good glycaemic control (HbA1c level <7%) was achieved only in 
7.4% of the T2DM subjects. Results of chi-square analysis showed that higher BMI (≥25 kg/m2) was signifi-
cantly associated with hypertension among the T2DM subjects (p<0.01). There were significant differences 
(p<0.05) between male and female subjects with respect to mean age, BMI, waist- and hip-circumference, 
and mean low-density lipoprotein (LDL) level. The results revealed that many factors, such as obesity, fami-
ly history of diabetes, dyslipidaemia, uncontrolled glycaemic status, sedentary lifestyles, and hypertension 
were prevalent among the T2DM subjects. The characterization of this risk profile will contribute to design-
ing more effective and specific strategies for screening and controlling T2DM in Gujarat, India.
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INTRODUCTION
Type 2 diabetes mellitus (T2DM) is a chronic, de-
bilitating disease characterized by insulin resist-
ance, impaired insulin secretion, and hyperglycae-
mia. It is the most prevalent metabolic condition 
and one of the major health and socioeconomic 
problems worldwide (1-3). It represents more than 
90% of the whole diabetic population in the world 
(4) and is responsible for 9% of global mortality cor-
responding to four million deaths per year. Since 
the beginning is insidious, there is an average delay 
of 3-5 years in diagnosis. By the time the condition 
is diagnosed, minimal changes responsible for mi-
crovascular and macrovascular complications are 
already present. This issue is further compounded 
by untreated diabetes because of ignorance or inac-
cessibility to treatment. Untreated diabetes may re-
sult in limb amputation, blindness, kidney failure, 
and neuropathy. T2DM is also associated with four-
fold increased risk of cardiovascular events and is 
a risk factor for doubling the risk of cardiovascular 
death (5-7).
The prevalence of T2DM has been rising world-
wide, and globally, more than 180 million people 
are suffering from it. In particular, epidemics of this 
disorder have taken place in developing societies 
(8-9). Global diabetic load mostly comes from In-
dia and China where more than 75% of diabetic 
subjects will live in 2025 (4). India, like many other 
developing countries, has witnessed a rapid epide-
miological transition in the last two decades. Cou-Patel M et al. Type 2 diabetes mellitus in Gujarat, India
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pled with this, there has been a dramatic improve-
ment of the Indian economy in terms of per-capita 
income. These dramatic changes have had a great 
impact on urbanization and lifestyle of the Indians. 
As a result, diabetes mellitus has become the main 
public-health problem and amenable to change 
through early recognition at the individual level 
and surveillance at the population level. Results of 
studies showed that India is facing three-fold rise in 
the prevalence of diabetes in urban (5-15%) and in 
rural (2-6%) areas (10-11). India tops in the world 
with the largest number of diabetic subjects (31.7 
million cases of T2DM) (3,12). This is further com-
pounded by the epidemic of obesity and doubling 
the cost of diabetes management (13). Therefore, 
prevention is important from monetary and from 
lifestyle modification point of view. Increasing 
awareness of risk factors and how to prevent these 
should be emphasized in the population (14). Apart 
from this, the lifestyle modifications (physical ex-
ercise, diet control, etc.) are appropriate measures 
in the prevention of diabetes. Furthermore, to con-
trol and prevent the T2DM epidemic, it must be 
approached in an appropriate, socioeconomically- 
and culturally-relevant manner but very little data 
are available from Gujarat to support this, and for 
the prevention of diabetes, it is also vital to know 
the profile of diabetics.    
This paper reports the profile of type 2 diabetic sub-
jects from Gujarat, India.  
MATERIALS AND METHODS
Study setting
A hospital-based observational study was conduct-
ed during August 2006–January 2009 in Ahmeda-
bad district of Gujarat state, India. Ahmedabad is 
the largest district of Gujarat with an approximate 
population of five million. The city is famous for 
medical tourism because of its wide network of 
cost-effective tertiary-care hospitals catering to 
the need of population of not only from Gujarat 
but also from neighbouring states and even from 
abroad.   
Study population
The study population comprised diabetic subjects. 
To be included in this study, it was a must for sub-
jects to be newly diagnosed for diabetes mellitus 
(diagnosed within the last 6 months), attending 
the Department of Diabetology, All India Institute 
of Diabetes and Research and Yash Diabetes Spe-
cialties Centre (Swasthya) during the study period 
for the first time and willing to participate in the 
study. 
Sample-size
A sample-size of 660 was decided on the basis of 
review of data of the Department of Diabetology 
which revealed that at least 100 subjects (newly-
diagnosed) were presented every month. Hence, 
there would be 3,000 subjects during the study pe-
riod. Of the 3,000 newly-diagnosed cases, at least 
20% were selected for this study. The calculated 
minimum sample-size was inflated by 10% to ac-
count for anticipated drop-outs. 
Procedure for data collection
After satisfying the case definition and obtaining 
informed consent (written consent from literate 
subjects and verbally informed consent from illit-
erate subjects), 709 subjects were enrolled through 
simple random-sampling method. After explaining 
the details of the study, a comprehensive case his-
tory was recorded on a semi-structured, close-ended 
proforma. Basic data on age, sex, education, occu-
pation, smoking and tobacco-chewing status, alco-
hol consumption, diet, and physical activity were 
collected from all the subjects. All the subjects were 
also interviewed regarding history of hypertension 
and other co-morbid conditions. A general physi-
cal examination was performed.
For analysis, the current smokers and ex-smokers 
were categorized in the ‘ever-smoker’ group. imi-
larly, the current tobacco chewers and ex-tobacco 
chewers were categorized in the ‘ever-tobacco 
chewer’ group. Both ever-smoker group and ever-
tobacco chewer group were considered tobacco us-
ers. Current alcohol users were defined as sub-
jects who have consumed alcohol at least once in 
the last one month. Mode of onset of diabetes 
was defined based on the duration of symptoms 
of diabetes present in the subjects and categorized 
as acute (symptoms present for up to one month), 
sub-acute (symptoms present from one to three 
months), and insidious (symptoms present from 
three to six months). The main occupational level 
was divided into three categories: low (e.g. skilled 
workers, household workers, and retired persons), 
medium (e.g. desk-jobs), and high (e.g. profession-
als and businessmen). Physical activity was catego-
rized as sedentary (sitting, standing, and driving 
for most of the day, cooking, light cleaning, light 
yard work, slow walking, and other major activities 
that involve sitting), moderate (an occupation that 
includes lifting, lots of walking, or other activities 
that keep you moving for several hours qualified 
as moderately active), and heavy (heavy manual 
labour, a very active lifestyle, dancer, or very ac-
tive sports played for several hours almost daily, an 
elite athlete in training, or an extremely active life-
style―both at work and at play and sport or activi- 
ty last for several hours, almost daily). Patel M et al.
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Anthropometric, clinical and biochemical 
measurements
All anthropometric measurements were recorded 
using standardized procedures. The study sub-
jects also underwent various clinical tests, such as 
urinalysis (first-morning urine sample for evalu-
ation of micro-albuminuria), blood tests for com-
plete haemogram, plasma glucose, glycosylated 
haemoglobin (HbA1c), renal function tests, and 
lipid levels. Blood samples were collected after en-
suring 12 hours of overnight fasting. Total choles-
terol (TC), triglycerides (TG), and high-density 
lipoprotein-cholesterol (HDL-C) levels were esti-
mated in serum. Low-density lipoprotein-choles-
terol (LDL-C) was calculated using the Friedewald 
formula [LDL-C (mg/dL)=non-HDL-C-TG/5] (15). 
Blood pressure was recorded after the subjects had 
rested for at least five minutes. Two readings were 
taken five minutes apart, and mean of the two was 
considered the actual blood pressure. Hyperten-
sion was diagnosed based on drug treatment for 
hypertension or if the blood pressure was >130/80 
mmHg according to the Joint National Commit-
tee-7 (JNC-VII) criteria (16-17). The diagnosis of 
diabetes mellitus was made using the criteria es-
tablished by the American Diabetes Association 
(18), i.e. a medical record indicating either a fast-
ing plasma glucose (FPG) level of >7.0 mmol/L or 
≥126 mg/dL after a minimum 12-hour fasting, or 
two-hour post glucose level (oral glucose tolerance 
test) of >11.1 mmol/L or ≥200 mg/dL on more than 
one occasion, with symptoms of diabetes. In the 
absence of information from the medical records, 
confirmation was done on self-reported case by es-
tablishing the criteria of regular treatment with an-
ti-diabetic drugs or by performing a two-hour oral 
glucose tolerance test (OGTT). Impaired glucose 
tolerance (IGT) was defined as the FPG level of 100 
mg/dL (5.6 mmol/L) but <126 mg/dL (7.0 mmol/L) 
or two-hour OGTT of ≥140 mg/dL (7.8 mmol/L) 
but <200 mg/dL (11.1 mmol/L). 
The guidelines of the National Cholesterol Educa-
tion Programme were used for defining dyslipidae-
mia (19). It was defined by presence of one or more 
than one abnormal serum lipid concentration, 
such as hypercholesterolaemia, high LDL-C, hyper-
triglyceridaemia, and low HDL-C. Body mass index 
(BMI) values were defined according to the recom-
mendations of the Indian Council of Medical Re-
search for Indians. A study subject was considered 
to be obese if BMI was ≥25 kg/m
2 and overweight 
when BMI was 23-24.9 kg/m2 (20). The criterion 
for glycaemic status was <7% (good control), 7-8% 
(sub-optimal control), 8-9% (inadequate control), 
and >9% (uncontrolled) (21).   
Analysis of data
Data were processed in Excel-sheet and analyzed 
using the SPSS software (version 11.5). Quantita-
tive variables were summarized using mean and 
standard deviation while categorical variables were 
tabulated using frequencies and percentages. Stu-
dent’s t-test was used for testing the significance of 
differences between the mean values of two con-
tinuous variables. Chi-square test was carried out 
to test the difference between two or more groups. 
The probability (p) level of less than 0.05 was con-
sidered significant.
Ehical approval
The Institutional Review Board of the All India In-
stitute of Diabetes and Research approved the study 
protocol.
RESULTS
A sample of 709 diabetic subjects was enrolled. Of 
the 709 subjects, 622 (88%) had T2DM. Hence, 
further analysis was performed on the 622 T2DM 
subjects. 
Sociodemographic characteristics
Sociodemographic characteristics of the study 
subjects are shown in Table 1. The type 2 diabetic 
subjects were evenly distributed in four quartiles of 
age with mean of 47.70±10.94 years. Of the study 
samples (n=622), 384 (62%) were male, and 238 
(38%) were female. Eighty-four percent (n=521) of 
the subjects were following religion of Hinduism, 
and most (99%) study subjects were literate. Thirty-
seven percent of the subjects had high level of oc-
cupation.  
Presenting complaints/symptoms
The subjects had classic diabetic symptoms. Of the 
622 subjects, 273 (44%) had nocturia, 192 (31%) 
had polyuria, and 145 (23%) had polydypsia. How-
ever, 57 (9%) subjects presented with vision impair-
ment (Table 2). 
Behavioural profile
The findings of the study showed that 173 (28%) 
of the 622 subjects had some form of habits. For 
example, 56 (9%) were smokers, 121 (20%) were 
tobacco chewers, and 51 (8%) were consuming al-
cohol. Most (84%) study subjects reported seden-
tary lifestyle (Table 3). 
Risk profile
A very few (7%) study subjects had good glycae-
mic control (HbA1c ≤7%). Two-thirds had positive Patel M et al. Type 2 diabetes mellitus in Gujarat, India
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Table 1. Sociodemographic characteristics of type 
2 diabetic subjects from Gujarat, India
Characteristics No. (n=622) %*
Age (years) (mean±SD) 47.70±10.94
   Up to 40 164 27
   41-48  170 27
   49-55 150 24
   >55 138 22
Sex
  Male 384 62
  Female 238 38
Marital status
   Never married 22 4
   Ever-married  600 96
Religion
   Hinduism 521 84
Islam  51 8
   Christianity  19 3
   Others 31 5
Education
   No education 03 1
   Primary school  18 3
   Secondary school 105 17
   College 420 67
   Professional (MBA,  
    CA, MBBS, etc.) 76 12
Occupation level
   Low 281 45
   Medium 112 18
   High 229 37
*All percentages rounded to whole numbers
family history of diabetes. The findings showed a 
mean BMI of 27.06±4.57. According to BMI, only 
16% of the sample subjects had normal weight; the 
majority was either overweight (BMI 23.0-24.9 kg/
m2) or obese (BMI ≥25 kg/m2). Microalbuminuria 
was found among 10% (n=62) of the subjects. Of 
the T2DM patients, 78% had dyslipidaemia, and 
47% had hypertension (Table 3). 
There was a significant (p<0.05) difference between 
the male and the female subjects with respect to mean 
age (male=46.93±11.11 years, female=48.95±10.53 
years), mean BMI (male=26.47±4.34, female=28.02± 
4.78),  mean  waist-circumference  (male=93.12±10.47 
cm, female=88.96±9.53 cm), mean hip-circumfer-
ence (male=98.46±8.83 cm, female=101.69±12.52 
cm) and mean LDL level (male=119.20±31.23, fe-
male=127.73±38.15) (Table 4). BMI was significant-
ly (p<0.001) associated with hypertension (Table 
5). 
DISCUSSION
Diabetes mellitus is a major public-health problem 
worldwide. Its prevalence is rising in many parts of 
the developing world, and India is no exception to 
this. It will become diabetes capital of the world in 
near future. Individuals with T2DM are considered 
on high priority as they are potential candidates for 
rapid evaluation to prevent and halt the progres-
sion of complications.  
This study presented observational data from a 
large number of subjects with diabetes attending 
the Department of Diabetology, All India Institute 
of Diabetes and Research and Yash Diabetes Spe-
cialties Centre. To the best of our knowledge, no 
such type of profiles has been reported from Gu-
jarat. Nonetheless, literature on the prevalence of 
diabetes is available from South and North India 
(22-24). Our main motivation for this analysis was 
to obtain the risk profile so that we can prevent or 
decrease the burden of T2DM in Gujarat.    
The present study found that T2DM is a major bur-
den in Gujarat, which is consistent with findings 
of Simon (4). The main findings of the study were: 
only 7% of the study population had good gly-
caemic control (HbA1c ≤7%), 68% of the subjects 
with T2DM were obese, and BMI was significantly 
(p<0.001) associated with hypertension. Our study 
population had a negligible proportion of illiterate 
T2DM subjects. This finding was expected, given 
that our sample was drawn from an urban tertiary-
care hospital. 
Achieving good glycaemic control in diabetic 
subjects has proven a real challenge to healthcare 
Table 2. Presenting symptoms of type 2 diabetic 
subjects from Gujarat, India
Manifestation of 
symptoms
No. 
(n=622) %*
Nocturia 273 44
Polyuria  192 31
Polydipsia 145 23
Vision impairment 57 9
Itching of private parts 50 8
Tingling 136 22
Weight loss 165 27
Weakness 365 59
Leg pain 155 25
Burning micturation 68 11
Skin complaint 59 10
Numbness 39 6
Impotence 28 5
*All percentages rounded to whole numbersPatel M et al.
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Table 3. Profile of clinical and other associated 
factors of type 2 diabetic subjects from 
Gujarat, India
Characteristics No. (n=622) %*
Glycosylated haemoglobin 
(HbA1c) (mean±SD) 9.02±1.67
Glycaemic status (%)
   <7 (good control) 46 7
   7-8 (sub-optimal control) 159 26
   8-9 (sub-optimal control) 163 26
   >9 (uncontrolled) 254 41
Family history of diabetes
   Present 417 67
BMI group
   Underweight (<18.5 kg/m2)    11 1
   Normal (18.5-22.9 kg/m2) 99 16
   Overweight (23.0-24.9 kg/m2) 92 15
Obese (≥25.0 kg/m2) 420 68
Microalbuminuria 62 10
Lipid
   Dyslipidaemia  487 78
Hypertension
   Present 289 47
Mode of onset
   Acute  446 72
   Sub-acute 145 23
   Insidious 31 5
Physical activity
   Sedentary 525 84
   Moderate    89 14
   Heavy  8 1
Diet control 103 17
Other diabetic treatments 
(excluding diet)
   Yes  219 35
Past history (of any 
medical/surgical condition)
   Yes  291 47
Smoking
   Yes  56 9
Years of tobacco smoking 
   (mean±SD) 11.46±9.27
Tobacco chewing
   Yes  121 20
Years of tobacco chewing
   (mean±SD) 12.37±8.61
Alcohol
   Yes  51 8
Years of alcohol drinking  
   (mean±SD) 9.68±7.64
*All percentages rounded to whole numbers;       
 SD=Standard deviation
providers. Studies have documented that self-care 
among T2DM subjects improved glycaemic control 
and reduced complications (25-26). In the present 
study, only 7% of the subjects had good glycaemic 
control, which is different from various studies. A 
Swedish survey found that 34% of type 2 diabetes 
subjects had good glycaemic control (27). Al-
Maskari F et al. found that 38% of T2DM subjects 
had good glycaemic control (28), and the study 
by Al-Kaabi J et al. reported that 31% of subjects 
had good glycaemic control (21). The possible ex-
planation may be that our study sample consisted 
of newly-diagnosed T2DM subjects drawn from a 
tertiary-care hospital, and non-adherence to inter-
ventions may contribute to uncontrolled glycae-
mic status (29). These subjects may have T2DM for 
many years as evident from complications, such as 
renal dysfunction in 9% and vision impairment in 
10% of the T2DM subjects. In the present study, 
the majority (68%) of the subjects with T2DM 
were obese. This is consistent with the findings of 
various studies (30-33). Obesity was also associated 
with family history of diabetes among the Indian 
population (34). Dyslipidaemia and hypertension 
were also related with the family history of diabetes 
through its link to BMI (32,35). The role of BMI as 
predictor for hypertension has been previously des- 
cribed (36), and the present study also confirmed 
the same among the T2DM subjects. Our study 
could not demonstrate any significant association 
among physical activity, dyslipidaemia, and con-
trolled glycaemic status with hypertension among 
the T2DM subjects. However, the age and family 
history of diabetes were marginally significant. 
Although diet control is the cornerstone in the 
management of T2DM, only 17% of the study sam-
ple was on diet therapy. 
Limitations
Several potential limitations should be considered 
in interpreting the results of the present study. First, 
the study is limited by cross-sectional design; so, 
temporality (cause-and-effect relationships) can-
not be established. It can, however, provide a clear 
snapshot of the current situation and may help im-
prove the management and design of future studies 
to explore further. Second, this is a hospital-based 
study in an urban set-up, which may not be rep-
resentative and applicable to general population. 
However, this could provide a reasonably precise 
and reliable estimate of the risk profile of T2DM 
in Gujarat. Third, we tried to include newly-diag-
nosed subjects but we are not sure that all subjects 
are newly diagnosed because we have relied on the 
subjects.Patel M et al. Type 2 diabetes mellitus in Gujarat, India
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Conclusions
The present study directed at providing the profile 
of the T2DM subjects from Gujarat, India, as an 
impetus for further exploration of the sociocultural 
and subject-related factors affecting the outcomes 
of T2DM care that, in turn, will lead to redefine the 
diabetes control and preventive strategies. The find-
ings of the study revealed that a high proportion of 
factors, such as obesity, family history of diabetes, 
dyslipidaemia, uncontrolled glycaemic status, sed-
entary lifestyles, and hypertension, were prevalent 
in the T2DM subjects. The findings also provide an 
early indication for development of T2DM-related 
complications. 
Based on the findings of the study, we recommend 
the following steps for the appropriate manage-
ment of T2DM subject: 
•	 Uncontrolled	glycaemic	status,	dyslipidaemia,	
and vision impairment should be taken care 
of by conducting early screening for complica-
tions, frequent check-ups, and follow-ups.
•	 Prevention	of	T2DM	needs	to	have	lifestyle	
modification interventions, i.e. body-weight 
control through diet and exercise should be 
emphasized.
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